Atlanpole Biotherapies
  • enfr
  • Atlanpole Biotherapies
    • About us
    • Approaches to excellence
      • Biotech / Pharma
      • MedTech
      • Digital Health
      • Disease Prevention
    • Team
    • Board of Directors
    • Funding
  • Our network
    • Members
    • Partners
    • European network
  • News & Events
    • Events
    • News
  • Services
    • Diversify your network
    • Broaden your horizons
    • Develop your innovation projects
    • Enhance your public profile
  • Contact
News

valneva-actu

      Home > Valneva confirms initiation of rolling review with EMA and provides updates on its COVID-19 vaccine program VLA2001 > valneva-actu
22 April 2021

All news
  • Linkedin
  • Mail
< Previous post
Back to list

Biotech / Pharma

MedTech

Digital Health

Disease Prevention

  • Legal Statement
  • Privacy policy for personal data
  • Events
  • News

Find us

  • Mail